David Kinsman

Follow

Person

Ashland, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Nicotinamide RIPK1 inhibitors
- Patent number 11,767,310
- Issue date Sep 26, 2023
- AbbVie Inc.
- Kevin Patrick Cusack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indazolones as modulators of TNF signaling
- Patent number 10,273,238
- Issue date Apr 30, 2019
- AbbVie Inc.
- Eric C. Breinlinger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indazolones as modulators of TNF signaling
- Patent number 9,879,016
- Issue date Jan 30, 2018
- AbbVie Inc.
- Eric Breinlinger
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NICOTINAMIDE RIPK1 INHIBITORS
- Publication number 20240360099
- Publication date Oct 31, 2024
- ABBVIE INC.
- Kevin Patrick Cusack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NICOTINAMIDE RIPK1 INHIBITORS
- Publication number 20230127127
- Publication date Apr 27, 2023
- ABBVIE INC.
- Kevin Patrick Cusack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDAZOLONES AS MODULATORS OF TNF SIGNALING
- Publication number 20180215764
- Publication date Aug 2, 2018
- ABBVIE INC.
- Eric C. Breinlinger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDAZOLONES AS MODULATORS OF TNF SIGNALING
- Publication number 20160304526
- Publication date Oct 20, 2016
- ABBVIE INC.
- Eric Breinlinger
- C07 - ORGANIC CHEMISTRY